Related Experiment Video
Updated: Sep 24, 2025
10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
7.0K
Brain metastasis: Recent treatment modalities and future-perspectives.
Atsuto Katano1, Hideomi Yamashita1
1Department of Radiology, University of Tokyo Hospital, Bunkyo, Tokyo 113-8655, Japan.
Oncology Letters
|May 9, 2022
Summary
Novel therapies and advanced radiotherapy are improving brain metastasis treatment. These approaches aim to enhance efficacy while minimizing cognitive side effects for better cancer patient outcomes.
Area of Science:
- Oncology
- Neurology
- Radiotherapy
Background:
- Advanced cancer treatment is evolving with molecular targeted therapy and immune checkpoint inhibitors.
- Brain metastasis frequency correlates with cancer genetics, posing unique treatment challenges.
- Conventional chemotherapy struggles to cross the blood-brain barrier, making radiotherapy crucial.
Purpose of the Study:
- To review the evolving landscape of brain metastasis management.
- To highlight the impact of novel systemic therapies and radiotherapy advancements.
- To emphasize the importance of optimizing treatment for patient quality of life.
Main Methods:
- Review of current literature on systemic therapies for advanced cancer.
- Analysis of radiotherapy techniques and their efficacy in brain metastasis.
- Discussion of adverse effects, particularly cognitive dysfunction from whole-brain radiotherapy (WBRT).
Main Results:
- Novel systemic agents show effectiveness against brain metastasis.
- Advances in radiotherapy allow for dose optimization with reduced adverse events.
- Whole-brain radiotherapy (WBRT) poses risks of late cognitive dysfunction.
Conclusions:
- Integrated approaches combining novel systemic therapies and advanced radiotherapy are transforming brain metastasis care.
- Minimizing adverse effects, especially cognitive decline, is key for improving patient prognosis and quality of life.
- Effective management of brain metastasis is integral to comprehensive cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K